Skip to main content

Table 3 Socio-demographic and clinical factors associated with severe adverse events

From: Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy

Characteristic at baseline

Case/n

Crude model

Adjusted model

OR(95%CI)

P

OR(95%CI)

P

Age, years

  < 50

77/428

1

   

  ≥ 50

8/46

0.96(0.43–2.14)

0.920

  

Marital status

 Single/divorced/widowed

63/367

0.80(0.47–1.38)

0.421

  

 Married/common law marriage

22/107

1

   

Years of Education

  ≤ 9

18/88

1.22(0.69–2.19)

0.495

  

  > 9

67/386

1

   

BMI, kg/m2

  < 24

54/351

1

 

1

 

  ≥ 24

31/123

1.85(1.12–3.06)

0.016

1.77(1.03–3.02)

0.038

CD4+, cells/mm3

  ≤ 199

21/120

1

   

 200–349

22/145

0.84(0.44–1.62)

0.843

  

 350–499

24/124

1.13(0.59–2.16)

0.656

  

  ≥ 500

18/85

1.27(0.63–2.56)

0.509

  

Viral load, cells/ml

  < 100,000

64/382

1

 

1

 

  ≥ 100,000

21/92

1.47(0.84–2.56)

0.175

1.55(0.86–2.81)

0.148

Syphilis Status

 Yes

24/149

0.83(0.50–1.40)

0.483

  

 No

61/325

1

   

Hepatitis Status

 Positive

7/31

1.37(0.57–3.28)

0.487

  

 Negative

78/443

1

   

WHO Clinical Stage

 I + II

75/433

1

   

 III + IV

10/41

1.54(0.72–3.28)

0.262

  

Pre-existing AE

 Yes

78/403

2.19(0.97–4.97)

0.060

0.96(0.39–2.34)

0.924

 No

7/71

1

 

1

 

Pre-existing multiple AE

 Yes

49/167

3.13(1.93–5.06)

< 0.001

2.72(1.59–4.64)

< 0.001

 No

36/307

1

 

1

 

Pre-existing severe AE

 Yes

18/36

5.54(2.74–11.19)

< 0.001

5.58(2.65–11.73)

< 0.001

 No

67/438

1

 

1

Â